---
pmid: '24722437'
title: Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
authors:
- Lenoir O
- Milon M
- Virsolvy A
- Hénique C
- Schmitt A
- Massé JM
- Kotelevtsev Y
- Yanagisawa M
- Webb DJ
- Richard S
- Tharaux PL
journal: J Am Soc Nephrol
year: '2014'
full_text_available: false
pmcid: PMC4005294
doi: 10.1681/ASN.2013020195
---

# Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
**Authors:** Lenoir O, Milon M, Virsolvy A, Hénique C, Schmitt A, Massé JM, Kotelevtsev Y, Yanagisawa M, Webb DJ, Richard S, Tharaux PL
**Journal:** J Am Soc Nephrol (2014)
**DOI:** [10.1681/ASN.2013020195](https://doi.org/10.1681/ASN.2013020195)
**PMC:** [PMC4005294](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005294/)

## Abstract

1. J Am Soc Nephrol. 2014 May;25(5):1050-62. doi: 10.1681/ASN.2013020195. Epub
2014  Apr 10.

Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.

Lenoir O(1), Milon M(1), Virsolvy A(2), Hénique C(1), Schmitt A(3), Massé JM(3), 
Kotelevtsev Y(4), Yanagisawa M(5), Webb DJ(6), Richard S(2), Tharaux PL(7).

Author information:
(1)Paris Cardiovascular Research Centre, Institut National de la Santé et de la 
Recherche Médicale, Paris, France; Université Paris Descartes, Sorbonne Paris 
Cité, Paris, France;
(2)Physiologie et Médecine expérimentale du Cœur et des Muscles, Institut 
National de la Santé et de la Recherche Médicale U1046, Université Montpellier 
1, Université Montpellier 2, Montpellier, France;
(3)Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Transmission 
Electron Microscopy Platform, Institut National de la Santé et de la Recherche 
Médicale U1016, Cochin Institut, Paris, France; Centre National de la Recherche 
Scientifique UMR81044, Paris, France;
(4)The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, 
United Kingdom; Pushchino State Institute for Natural Sciences, Pushchino, 
Moscow Region, Russian Federation;
(5)University of Texas Southwestern Medical Center, Dallas, Texas; and.
(6)The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, 
United Kingdom;
(7)Paris Cardiovascular Research Centre, Institut National de la Santé et de la 
Recherche Médicale, Paris, France; Université Paris Descartes, Sorbonne Paris 
Cité, Paris, France; Nephrology Service, Georges Pompidou European Hospital, 
Assistance Publique Hopitaux de Paris, Paris, France 
pierre-louis.tharaux@inserm.fr.

Comment in
    J Am Soc Nephrol. 2014 May;25(5):869-71. doi: 10.1681/ASN.2014020174.

The endothelin system has emerged as a novel target for the treatment of 
diabetic nephropathy. Endothelin-1 promotes mesangial cell proliferation and 
sclerosis. However, no direct pathogenic effect of endothelin-1 on podocytes has 
been shown in vivo and endothelin-1 signaling in podocytes has not been 
investigated. This study investigated endothelin effects in podocytes during 
experimental diabetic nephropathy. Stimulation of primary mouse podocytes with 
endothelin-1 elicited rapid calcium transients mediated by endothelin type A 
receptors (ETARs) and endothelin type B receptors (ETBRs). We then generated 
mice with a podocyte-specific double deletion of ETAR and ETBR 
(NPHS2-Cre×Ednra(lox/lox)×Ednrb(lox/lox) [Pod-ETRKO]). In vitro, treatment with 
endothelin-1 increased total β-catenin and phospho-NF-κB expression in wild-type 
glomeruli, but this effect was attenuated in Pod-ETRKO glomeruli. After 
streptozotocin injection to induce diabetes, wild-type mice developed mild 
diabetic nephropathy with microalbuminuria, mesangial matrix expansion, 
glomerular basement membrane thickening, and podocyte loss, whereas Pod-ETRKO 
mice presented less albuminuria and were completely protected from 
glomerulosclerosis and podocyte loss, even when uninephrectomized. Moreover, 
glomeruli from normal and diabetic Pod-ETRKO mice expressed substantially less 
total β-catenin and phospho-NF-κB compared with glomeruli from counterpart 
wild-type mice. This evidence suggests that endothelin-1 drives development of 
glomerulosclerosis and podocyte loss through direct activation of endothelin 
receptors and NF-κB and β-catenin pathways in podocytes. Notably, both the 
expression and function of the ETBR subtype were found to be important. 
Furthermore, these results indicate that activation of the endothelin-1 pathways 
selectively in podocytes mediates pathophysiologic crosstalk that influences 
mesangial architecture and sclerosis.

Copyright © 2014 by the American Society of Nephrology.

DOI: 10.1681/ASN.2013020195
PMCID: PMC4005294
PMID: 24722437 [Indexed for MEDLINE]
